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Zaitlen et al., page 23
As the number of variants identiﬁed as being associated
with complex disease increases, one caveat about the
results is that the variant identiﬁed may not be the func-
tional variant contributing to disease risk, but may simply
be in linkage disequilibrium (LD) with the causal variant.
Regions of LD are advantageous in that they allow
researches to ‘‘tag’’ a large amount of sequence with a small
set of markers, but dissecting which variant within such an
LD block is causal is difﬁcult. Fine mapping via high-
density genotyping or sequencing can help to break up
the LD in an area, and work has begun to determine which
populations should be used for such follow-up studies. By
evaluating the regions in populations with different LD
structure, it might be possible to differentiate the associa-
tion signal of one marker from another. Here, Zaitlen and
colleagues analyze which population or set of populations
is most useful in the quest to successfully zero in on the
functional variant. Although it has been hypothesized
that using a population with as little LD as possible, such
as the African population, would contribute the most to
such a project, the authors ﬁnd that a combination of pop-
ulations often yields the best results. The authors also note
that the best choice of population set is locus speciﬁc.
These analyses are compiled into software called MULTI-
POP which will allow users to establish their ideal study
design in the most cost-efﬁcient manner.X Chromosome Evolution
Lambert et al., page 34
Because of the special characteristics of the X chromosome,
studying its population structure can be a bit more compli-
cated than the same type of analysis of the autosomes. The
fact that males are hemizygous for the X chromosome
leads to increases in the differentiation at X-linked loci
and to a smaller effective population size, which contrib-
utes to increases in the effect of drift. It has been reported
previously that the X chromosome has, on average, larger
allele frequency differences than the autosomes. Here,
Lambert and colleagues use X chromosome data from
a number of populations to look more closely at the differ-
entiation of X-linked markers on a region-speciﬁc basis.
The authors start by looking at the X-linked SNPs in the1Science Editor, AJHG; 2Deputy Editor, AJHG
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ThHapMap data that have extreme allele frequency differ-
ences. They identify ﬁve distinct regions along the X chro-
mosome in which these most highly differentiated SNPs
reside. In support of these ﬁndings, the PerlegenX chromo-
some SNPs with high allele frequency differences cluster in
the same regions. Closer analysis of these regions identiﬁes
evidence of recent positive selection. Of particular note is
that Lambert and colleagues identify within the cluster
that resides near the centromere a high concentration of
markers for which the derived allele is at a very high
frequency in African populations, but for which the ances-
tral allele is more common in non-African populations.
This is contrary to the situation that is most frequently
encountered. This suggests that this region of the X chro-
mosome has undergone selective pressures in the African
populations that differ from those that have affected
non-African populations.C16orf57 Poikiloderma with Neutropenia
Volpi et al., page 72
Next-generation sequencing (NGS) has the power to accu-
rately sequence long stretches of DNA from diverse regions
of the genome. This is possible through use of a sequencing
technique called massively parallel sequencing. As the
name implies, the technique ampliﬁes DNA from different
regions of the genome concomitantly. After assembly of
the sequences produced, sequences of entire genes or
even chromosomes can be deciphered. Although different
companiesusediverse approaches toobtain sequence infor-
mation from different parts of the genome simultaneously,
they all promise increased throughput for a reduced cost.
Here, Volpi and colleagues use NGS to identify a mutation
in patients displaying a genetic skin disease characterized
by poikiloderma (a type of altered pigmentation), pachyo-
nychia (thick nails), and chronic neutropenia. Although
initially diagnosed as having Rothmund-Thomson syn-
drome (RTS), the chronic neutopenia and absence of
RECQL4 mutations, present in two thirds of RTS patients,
changes the diagnosis of these patients to poikiloderma
with neutropenia (NP). Linkage analysis is used to iden-
tify a 3.4 Mb candidate region on chromosome 16q con-
taining more than 80 annotated genes. Because classical
sequencing would take a tremendous amount of time and
money, this group utilizes NGS, which reveals 17 unre-
portedhomozygousmismatches foundwithin or very closeGenetics. All rights reserved.
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to genes. Further analysis reveals a splice-site mutation in
C16orf57. Additional C16orf57 mutations are then found
in a separate patient with NP, conﬁrming that mutations
in this gene as causative for NP. In addition to demon-
strating the utility of NGS, these data can now be used to
distinguish atypical RTS patients from those with PN.A Mutation in the PDE8B Gene Causes ADSD
Appenzeller et al., page 83
PDEs are cyclic nucleotide phosphodiesterases that degrade
phosphodiester bonds in the second messenger molecules
cyclic AMP (cAMP) and cyclic GMP. These second messen-
gers are involved in the process of signal transduction.
For example, cAMP is responsible for transferring the
effects of small molecules such as hormones across cell
membranes. One way in which these second messengers
act is through the activation of protein kinases. Currently,
inhibitors of PDEs are being used to treat disorders that2 The American Journal of Human Genetics 86, 1–2, January 8, 2010would beneﬁt from delayed degradation of these second
messenger molecules. Some of these disorders are erectile
dysfunction, dementia, and hypertention. Here, Appenzel-
ler and colleagues identify a frameshift mutation in
PDE8B in a family affected with autosomal-dominant stria-
tal degeneration (ADSD). ADSD is characterized by slow
execution ofmovement (bradykinesia), dysarthria (amotor
speech disorder), and muscle rigidity. Bradykinesia and
rigidity are two key features of Parkinson disease (PD), indi-
cating that the same region of the brain is involved in these
two disorders. PDE8B encodes phosphodiesterase 8B and
selectively hydrolyzes 30,50-cAMP to 50-AMP. The authors
suggest that PDE8B may inﬂuence dopaminergic neuro-
transmission in the striatum, the region of the brain
affected in both PD and ADSD. This is plausible, given
that dopamine receptors in the striatum are known to stim-
ulate cAMP synthesis. More work is necessary to decipher
the true role of PDE8B in neurological function; however,
thiswork gets us one step closer to the answer and identiﬁes
a gene involved in ADSD.
